This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight
BioDrugs Open Access 15 March 2024
-
A qPCR method for genome editing efficiency determination and single-cell clone screening in human cells
Scientific Reports Open Access 11 December 2019
-
A few ethical issues in translational research for gene and cell therapy
Journal of Translational Medicine Open Access 28 November 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Sangamo's landmark genome editing trial gets mixed reception. Nat Biotechnol 36, 907–908 (2018). https://doi.org/10.1038/nbt1018-907
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1018-907
This article is cited by
-
Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight
BioDrugs (2024)
-
The current landscape of nucleic acid therapeutics
Nature Nanotechnology (2021)
-
Treating genes and patients
Gene Therapy (2020)
-
Lysosomal storage diseases: current therapies and future alternatives
Journal of Molecular Medicine (2020)
-
A few ethical issues in translational research for gene and cell therapy
Journal of Translational Medicine (2019)